Florbetaben F-18 Injection Amyloid Plaque RadioPharmaceutical

Special Notice Posted

Solicitation number
36C24819Q1344
Agency
Set-aside
No set-aside

Opportunity facts

NAICS code
325412 Pharmaceutical Preparation Manufacturing

Notice details come from SAM.gov. Updated .

Notice text

This is not a solicitation for quotes.
This is a notice of contract action (NOCA). The purpose of this NOCA is to provide notification of the Department of Veterans Affairs (VA) intent of contract action to make a sole source award in accordance with FAR Part 6.302-1.
Notice of Contract Action: Network Contracting Office (NCO) 8 intends to issue a sole source, firm fixed price contract with a base year and four option years, using other than full and open competition, to SOFIE, Co. for the purchase of FDA approved Neuraceq Florbetaben F-18 Injections for the VA Healthcare Center Miami. Estimated value of this acquisition is approximately $110,000.00/year and $550,000/including base and option years. The estimated award date is on or before September 01, 2019.
Qualified sources may submit a quote (or capabilities statement) which shall be considered but shall in no way bind the agency. Reimbursement will not be made for any costs associated with providing or requesting information in response to this NOCA.
Responses shall be submitted via email to Deborah.Murphy3@va.gov and received no later than 12:00 PM Tuesday, August 20, 2019..

Files

File Type Posted
36C24819Q1344-000.docx DOCX document

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors